Raw Materials & Excipients Management – Page 42

Risk mitigation plan inadequate during submission support – risk mitigation and control strategy

The first step in identifying potential risk inadequacies is recognizing early symptoms or signals of non-compliance within production and laboratory environments. These signals may include:Click to read the full article.

FIFO not followed during inventory reconciliation – product quality impact assessment

Significant deviations from FIFO practices often manifest through various symptoms or signals in both manufacturing environments and laboratories. Recognizing these signals is crucial for timely intervention.Click to read the full…

Potential nitrosamine source identified during supplier audit – preventing product recall

Identifying symptoms of potential nitrosamine contamination requires vigilant monitoring of various processes. Here are some indicators that may signal a risk:Click to read the full article.

Labeling deficiencies during warehouse operations – CAPA for warehouse failures

Recognizing the signals of labeling deficiencies is critical for timely intervention. Symptoms can range from minor discrepancies to significant errors that threaten compliance.Click to read the full article.

Supplier nitrosamine control weak during ongoing surveillance – FDA/EMA nitrosamine expectations

Identifying early signs of potential nitrosamine contamination is crucial. Symptoms can often manifest through various channels—here are key signals to monitor:Click to read the full article.

Labeling deficiencies during deviation investigation – GMP storage compliance requirements

The first step in any deviation investigation is recognizing the symptoms or signals that indicate a labeling deficiency. Common signs include:Click to read the full article.

Analytical method sensitivity questioned during submission support – risk mitigation and control strategy

Identifying early warning signs of potential sensitivity issues in analytical methods can help providers manage risk proactively. Some common symptoms may include:Click to read the full article.

Environmental monitoring gaps during warehouse operations – inspection defense documentation

Identifying initial symptoms or signals is the first step in investigating environmental monitoring lapses. Symptoms may manifest as:Click to read the full article.

Regulatory query on nitrosamines during supplier audit – CAPA for nitrosamine findings

Understanding the symptoms or signals that may indicate nitrosamine-related issues is vital for prompt action. Here are a few indicators that manufacturing teams and quality control personnel should monitor:Click to…

Expired material used during inspection walkthrough – product quality impact assessment

Assessing the Impact of Expired Materials During Inspection Walkthroughs In pharmaceutical manufacturing, compliance with Good Manufacturing Practices (GMP) is paramount. One critical concern that can arise during inspection walkthroughs is…

Regulatory query on nitrosamines during supplier audit – inspection-ready justification

Recognizing potential issues with nitrosamines begins with identifying symptoms in the manufacturing and testing environments. Key indicators may include:Click to read the full article.

Labeling deficiencies during inventory reconciliation – CAPA for warehouse failures

Identifying symptoms or signals is the first step in addressing labeling deficiencies. Common indicators can include:Click to read the full article.